Investors v. Bayer

Reference :

No description

Complaint date :

December 30, 2021

Status :

Not judged

Place of jurisdiction :

Germany, Cologne (Köln)

Plaintiffs types :

Economic stakeholders

Plaintiffs names :

Institutional investors (banks, asset management companies, insurance companies and pension funds) and private investors

Defendants :

Bayer

Lawyers for Health and Environmental Justice :

Christian Herrmann, Axel Wegner (TILP)

Case nature :

Civil court

Specificities :

Class action

Type(s), Product(s), Active substance(s) :

Glyphosate

Requests :

Damages of approximately €2.2 billion for Bayer's breach of its obligation to inform investors of the financial risks associated with the acquisition of Monsanto.

Name of the Court :

High Court of Cologne (Köln), Germany

Jurisdiction level :

Summary :

Investors believe that Bayer violated its obligations related to the law on capital markets in its 2018 acquisition of Monsanto by failing to adequately inform them about the financial risks caused by Monsanto's glyphosate-related legal proceedings. On December 15, 2021, the Cologne court agreed to publish the application to initiate model proceedings in favor of the investment. Since then, TILP law firm has filed claims for damages against Bayer on behalf of approximately 320 investors. The court must now determine whether or not Bayer concealed from the market significant financial risks associated with its Monsanto acquisition.

Scientific references :

No scientifice reference for this case.